Gastroretentive hydrodynamically balanced systems of ofloxacin: In vitro evaluation

Saudi Pharmaceutical Journal

Volumn 21, Issue 1, 2013, Pages 113-117

  Nayak, Amit Kumar ^a   Das, Biswarup ^a   Maji, Ruma ^a  

^a SEEMANTA INSTITUTE OF PHARMACEUTICAL SCIENCES   (India)

Author keywords

Capsules; Drug release; Gastroretention; HPMC K4M; Hydrodynamically balanced system; Ofloxacin

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; LACTOSE; LIQUID PARAFFIN; OFLOXACIN; POVIDONE;

ARTICLE; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; GASTROINTESTINAL TRACT; HIGUCHI MODEL; HYDRODYNAMICALLY BALANCED SYSTEM; HYDRODYNAMICS; IN VITRO STUDY; MATHEMATICAL MODEL; MEAN RESIDENCE TIME; REACTION TIME; STOMACH ABSORPTION;

EID: 84871953305     PISSN: 13190164     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsps.2011.11.002     Document Type: Article

References (32)

1. Ali J., Arora S., Ahuja A., Babbar A.K., Sharma R.K., Khar R.K., Baboota S. Formulation and development of hydrodynamically balanced system for metformin: In vitro and in vivo evaluation. Eur. J. Pharm. Biopharm. 2007, 67:196-201.
2. Ali J., Hasan S., Ali M. Formulation and development of gastroretentive drug delivery system for ofloxacin. Methods Find. Exp. Clin. Pharmacol. 2006, 28:1-7.
3. Arrora S., Ali J., Khar R.K., Baboota S. Floating drug delivery systems: A review. AAPS PharmSciTech. 2005, 6(3):372-390.
4. Blagoeva R., Nedev A. Monolithic controlled delivery systems: Part II. Basic mathematical models. Bioautomation 2006, 5:106-117.
5. Chavanpatil M.D., Jain P., Chaudhari S., Shear R., Vavia P.R. Novel sustained release, swellable and bioadhesive gastroretentive drug delivery system for ofloxacin. Int. J. Pharm. 2006, 316:86-92.
6. Chen J., Blevins W.E., Park H., Park K. Gastric retention properties of superporous hydrogel composites. J. Control. Release 2000, 65:73-82.
7. Chowdary K.P.R., Rao Y.S. Mucoadhesive microspheres for oral controlled drug delivery. Biol. Pharm. Bull. 2004, 27:717-1724.
8. Cui Y., Zhang Y., Tang X. In vitro and in vivo evaluation of ofloxacin sustained release pellets. Int. J. Pharm. 2008, 360:47-52.
9. Dorozynski, P., Kulinowski, P., Jachowicz, R. and Jasinski, A. (2007). Development of a simultaneous studies and magnetic resonance imaging of water transport in hydrodynamically balanced systems: A technical note. AAPS PharmSciTech. 8(1): Article 15.
10. Fujimori J., Machida Y., Nagai T. Preparation of a magnetically-responsive tablet and configuration of its gastric residence in beagle dogs. STP Pharma. Sci. 1994, 4:425-430.
11. Garg R., Gupta G.D. Progress in controlled gastroretentive delivery systems. Trop. J. Pharm. Res. 2008, 7(3):1055-1066.
12. Higuchi T. Rate of release of medicaments from ointment bases containing drugs in suspension. J. Pharm. Sci. 1961, 50:874-875.
13. Janardhan D., Sreekanth J., Bharat V., Subramaniyan P.R. Formulation and evaluation of gastro retentive drug delivery system for ofloxacin. Int. J. Pharm. Sci. Nanotechnol. 2009, 2(1):428-434.
14. Klausner E.A., Lavy E., Friedman M., Hoffman A. Expandable gastroretentive dosage forms. J. Control. Release 2003, 90:143-162.
15. Korsmeyer R.W., Deolkar G.E.P., Peppas N.A. Mechanisms of potassium chloride from compressed, hydrophilic, polymeric matrices: effect of entrapped air. J. Pharm. Sci. 1983, 72:1189-1191.
16. Mulye N.V., Turco S.T. An examination of assumptions underlying the first-order kinetic model for release of water soluble drugs from dicalcium phosphate dehydrate matrices. Drug Dev. Ind. Pharm. 1996, 22(7):673-679.
17. Nayak A.K., Hasnain M.S., Beg S., Alam M.I. Mucoadhesive beads of gliclazide: Design, development, and evaluation. Sci. Asia 2010, 36:319-325.
18. Nayak A.K., Maji R., Das B. Gastroretentive drug delivery systems: a review. Asian J. Pharm. Clin. Res. 2010, 3(1):2-10.
19. Nayak A.K., Malakar J., Sen K.K. Gastroretentive drug delivery technologies: Current approaches and future potential. J. Pharm. Educ. Res. 2010, 1(2):1-12.
20. Rouge N., Allemann E., Gex-Fabry M., Balant L., Cole E.T., Buri P., Doelker E. Comparative pharmacokinetic study of a floating multiple-unit capsule, a high density multiple-unit capsule and an immediate-release tablet containing 25 mg atenolol. Pharm. Acta Helbetiae. 1998, 73:81-87.
21. Sahni J.K., Ahmad F.J., Ahuja A., Khar R.K. Formulation and evaluation of a hydrodynamically balanced system of paracetamol. The Indian Pharmacist. 2006, (46):64-66.
22. Salunke, R.J., Shahi, S.R. and Atram, S.C. (2009). Formulation and evaluation of hydrodynamically balanced system of ciprofloxacin HCl. Int. J. Pharm. Res. Dev. 7: Article 001.
23. Semalty M., Yadav S., Semalty A. Preparation and characterization of gastroretentive floating microspheres of ofloxacin hydrochloride. Int. J. Pharm. Sci. Nanotechnol. 2010, 3(1):819-823.
24. Seth P.R., Tossounian J. The hydrodynamically balanced system, a novel drug delivery system for oral use. Drug Dev. Ind. Pharm. 1984, 10:313-339.
25. Siepmann J., Peppas N.A. Modeling of drug release from delivery systems based on hydroxypropyl methylcellulose (HPMC). Adv. Drug Del. Rev. 2001, 48:139-157.
26. Sing B.N., Kim K.H. Floating drug delivery systems: an approach to oral controlled drug delivery via gastric retention. J. Control. Release 2000, 63:235-259.
27. Tadros M.I. Controlled-release effervescent floating matrix tablets of ciprofloxacin hydrochloride: Development, optimization and in vitro-in vivo evaluation in healthy human volunteers. Eur. J. Pharm. Biopharm. 2010, 74:332-339.
28. Tripathy, K.D. (2003). Sulfonamides, cotrimoxazole and qunolones. In: Essentials of Medical Pharmacology. 5th edition, section 12, chapter 48, Jaypee Brothers Medical Publishers (P) Ltd. New Delhi, India, pp. 646-652.
29. Varelas C.G., Dixon D.G., Steiner C. Zero-order release from biphasic polymer hydrogels. J. Control. Release 1995, 34:185-192.
30. Wamorkar V.V., Varmal M.M., Vijay Kumar B., Reddy V.M. Effect of hydrophilic and hydrophobic polymers and in vitro evaluation of hydrodynamically balanced system of metoclopramide hydrochloride. Int. J. Pharm. Sci. Nanotechnol. 2010, 3(3):1129-1135.
31. Wason R., Nanda A. Development and optimization of a gastroretentive FDDS using ciprofloxacin hydrochloride. The Indian Pharmacist. Dec: 2009, 81-89.
32. Zivanovic L., Zigic G., Zecevic M. Investigation of chromatographic conditions for the separation of ofloxacin and its degradation products. J. Chromatogr. A. 2006, 1119:224-230.